Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.62% | 27.46% | 15.95% | -11.52% | -20.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.62% | 27.46% | 15.95% | -11.52% | -20.49% |
| Cost of Revenue | 13.68% | 12.94% | 679.59% | -39.95% | -31.94% |
| Gross Profit | 106.05% | 49.45% | -58.85% | 91.26% | 12.00% |
| SG&A Expenses | 29.18% | 36.47% | 1.78% | -0.75% | 6.11% |
| Depreciation & Amortization | -7.63% | 1.00% | 5.55% | -5.30% | 5.13% |
| Other Operating Expenses | 45.58% | -53.29% | -392.81% | -106.80% | 12.79% |
| Total Operating Expenses | 22.05% | 7.01% | 5.25% | -13.11% | 4.23% |
| Operating Income | -15.20% | -0.46% | -2.49% | 13.56% | -13.71% |
| Income Before Tax | -19.04% | -11.14% | -10.99% | 14.60% | -14.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.04% | -11.14% | -10.99% | 14.60% | -14.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.29% | 30.43% | 12.61% | -21.98% | 8.96% |
| Net Income | -19.03% | -11.07% | -10.99% | 14.58% | -14.21% |
| EBIT | -15.20% | -0.46% | -2.49% | 13.56% | -13.71% |
| EBITDA | -20.35% | 0.15% | -2.08% | 13.80% | -7.70% |
| EPS Basic | 43.22% | 50.47% | 51.78% | 69.22% | 76.09% |
| Normalized Basic EPS | 43.80% | 54.84% | 55.23% | 69.21% | 76.09% |
| EPS Diluted | 43.22% | 50.47% | 51.87% | 69.22% | 76.09% |
| Normalized Diluted EPS | 43.80% | 54.84% | 55.23% | 69.21% | 76.09% |
| Average Basic Shares Outstanding | 109.61% | 124.27% | 130.15% | 177.50% | 377.47% |
| Average Diluted Shares Outstanding | 109.61% | 124.27% | 130.15% | 177.50% | 377.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |